Ma Songjiang

Ma Songjiang is listed in filings as President at Gyre Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 29, 2025, including sale activity. Recent filings connect the profile to Gyre Therapeutics, Inc. (GYRE). The current snapshot covers public activity from Dec 23, 2024 to May 29, 2025. Reported amounts are shown as $5.6K to $1.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.